BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38305491)

  • 1. Disseminated intravascular coagulation score evolution in 48 h predicts early death in acute promyelocytic leukemia patients.
    Infante JB; Esteves GV; Raposo J; de Lacerda JF
    Eur J Haematol; 2024 May; 112(5):840-844. PubMed ID: 38305491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of oral arsenic and all-trans-retinoic acid on coagulopathy in acute promyelocytic leukemia.
    Zhu HH; Guo ZP; Jia JS; Jiang Q; Jiang H; Huang XJ
    Leuk Res; 2018 Feb; 65():14-19. PubMed ID: 29232592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: a retrospective study.
    Baysal M; Gürsoy V; Hunutlu FC; Erkan B; Demirci U; Bas V; Gulsaran SK; Pinar IE; Ersal T; Kirkizlar TA; Atli EI; Kirkizlar HO; Ümit EG; Gürkan H; Ozkocaman V; Ozkalemkas F; Demir AM; Ali R
    Ann Hematol; 2022 May; 101(5):1049-1057. PubMed ID: 35190843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of empirical treatment for newly diagnosed acute promyelocytic leukemia combined with disseminated intravascular coagulation].
    Yang H; Zhu CY; Wang QS; Niu JH; Zhang Q; Zhu HY; Yao ZL; Xu YY; Jing Y; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):315-22. PubMed ID: 24762998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombomodulin alfa treatment in patients with acute promyelocytic leukemia and disseminated intravascular coagulation: a retrospective analysis of an open-label, multicenter, post-marketing surveillance study cohort.
    Matsushita T; Watanabe J; Honda G; Mimuro J; Takahashi H; Tsuji H; Eguchi Y; Kitajima I; Sakata Y
    Thromb Res; 2014 May; 133(5):772-81. PubMed ID: 24636871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and treatment outcomes of six patients with disseminated intravascular coagulation resulting from acute promyelocytic leukemia and treated with recombinant human soluble thrombomodulin at a single institution.
    Kawano N; Kuriyama T; Yoshida S; Yamashita K; Ochiai H; Nakazaki S; Tasaki A; Ueda A
    Intern Med; 2013; 52(1):55-62. PubMed ID: 23291674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microgranular acute promyelocytic leukemia presenting with leukopenia and an unusual immunophenotype.
    McDonnell MH; Smith ET; Lipford EH; Gerber JM; Grunwald MR
    Hematol Oncol Stem Cell Ther; 2017 Mar; 10(1):35-38. PubMed ID: 26806461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-life outcomes of unselected acute promyelocytic leukemia patients: a single-center 14-year experience.
    Akcay OF; Yeter HH; Buyukasik Y
    Rom J Intern Med; 2020 Sep; 58(3):138-145. PubMed ID: 32452194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of disseminated intravascular coagulation in acute leukemia reveals markedly elevated D-dimer levels are a sensitive indicator of acute promyelocytic leukemia.
    Shahmarvand N; Oak JS; Cascio MJ; Alcasid M; Goodman E; Medeiros BC; Arber DA; Zehnder JL; Ohgami RS
    Int J Lab Hematol; 2017 Aug; 39(4):375-383. PubMed ID: 28422420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of Chinese disseminated intravascular coagulation scoring system (version 2017) in patients with acute promyelocytic leukemia].
    Huang YT; Liu XF; Fu RF; Chen YF; Liu W; Xue F; Zhang L; Yang RC
    Zhonghua Xue Ye Xue Za Zhi; 2018 Jun; 39(6):480-484. PubMed ID: 30032565
    [No Abstract]   [Full Text] [Related]  

  • 11. International Society of Thrombosis and Hemostasis Scoring System for disseminated intravascular coagulation ≥ 6: a new predictor of hemorrhagic early death in acute promyelocytic leukemia.
    Mitrovic M; Suvajdzic N; Bogdanovic A; Kurtovic NK; Sretenovic A; Elezovic I; Tomin D
    Med Oncol; 2013 Mar; 30(1):478. PubMed ID: 23371042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined therapy with all-trans-retinoic acid and high-dose chemotherapy in patients with hyperleukocytic acute promyelocytic leukemia and severe visceral hemorrhage.
    Dombret H; Sutton L; Duarte M; Daniel MT; Leblond V; Castaigne S; Degos L
    Leukemia; 1992 Dec; 6(12):1237-42. PubMed ID: 1453767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of very early death in acute promyelocytic leukemia: a retrospective real-world cohort study.
    Infante J; Esteves G; Raposo J; de Lacerda JF
    Ann Hematol; 2023 Nov; 102(11):3031-3037. PubMed ID: 37650885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disseminated Intravascular Coagulation in Acute Promyelocytic Leukemia Patients: A Retrospective Analysis of Outcomes and Healthcare Burden in US Hospitals.
    Patel R; Patel D; Patel M; Ohemeng-Dapaah J; Onyechi A; Patel Z; Yang C; Shaikh S
    Turk J Haematol; 2024 Mar; 41(1):1-8. PubMed ID: 38374587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of factors affecting hemorrhagic diathesis and overall survival in patients with acute promyelocytic leukemia.
    Lee HJ; Kim DH; Lee S; Koh MS; Kim SY; Lee JH; Lee S; Oh SY; Han JY; Kim HJ; Kim SH
    Korean J Intern Med; 2015 Nov; 30(6):884-90. PubMed ID: 26552464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of cytokines on early death and coagulopathy in newly diagnosed patients with acute promyelocytic leukemia.
    Zhao S; Ge Y; Li Z; Yang T
    Front Immunol; 2023; 14():1100151. PubMed ID: 37063881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation patterns of disseminated intravascular coagulation in acute promyelocytic leukemia.
    Higuchi T; Shimizu T; Mori H; Niikura H; Omine M
    Hematol Oncol; 1997 Nov; 15(4):209-17. PubMed ID: 9722892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapy.
    Abla O; Ribeiro RC; Testi AM; Montesinos P; Creutzig U; Sung L; Di Giuseppe G; Stephens D; Feusner JH; Powell BL; Hasle H; Kaspers GJL; Dalla-Pozza L; Lassaletta A; Tallman MS; Locatelli F; Reinhardt D; Lo-Coco F; Hitzler J; Sanz MA
    Ann Hematol; 2017 Sep; 96(9):1449-1456. PubMed ID: 28597167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arsenic trioxide and all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia in all risk groups: study protocol for a randomized controlled trial.
    Zhang X; Zhang H; Chen L; Wang M; Xi J; Liu X; Xie M; Li D; Gulati ES; Gong S; Wang H
    Trials; 2018 Sep; 19(1):476. PubMed ID: 30185214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.